125 related articles for article (PubMed ID: 21803623)
21. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
[TBL] [Abstract][Full Text] [Related]
23. CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites.
Ahlström MM; Ridderström M; Zamora I
J Med Chem; 2007 Nov; 50(22):5382-91. PubMed ID: 17915853
[TBL] [Abstract][Full Text] [Related]
24. Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.
Bouaziz-Terrachet S; Toumi-Maouche A; Maouche B; Taïri-Kellou S
J Mol Model; 2010 Dec; 16(12):1919-29. PubMed ID: 20237816
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2).
Sharma SK; Al-Hourani BJ; Wuest M; Mane JY; Tuszynski J; Baracos V; Suresh M; Wuest F
Bioorg Med Chem; 2012 Apr; 20(7):2221-6. PubMed ID: 22386983
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors.
Jiang B; Zeng Y; Li MJ; Xu JY; Zhang YN; Wang QJ; Sun NY; Lu T; Wu XM
Arch Pharm (Weinheim); 2010 Sep; 343(9):500-8. PubMed ID: 20842641
[TBL] [Abstract][Full Text] [Related]
27. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A
Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914
[TBL] [Abstract][Full Text] [Related]
29. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
31. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
32. Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development.
Singh S; Pandey VP; Naaz H; Singh P; Dwivedi UN
Comput Biol Med; 2013 Jul; 43(6):744-50. PubMed ID: 23668350
[TBL] [Abstract][Full Text] [Related]
33. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of loxoprofen derivatives.
Yamakawa N; Suemasu S; Matoyama M; Tanaka K; Katsu T; Miyata K; Okamoto Y; Otsuka M; Mizushima T
Bioorg Med Chem; 2011 Jun; 19(11):3299-311. PubMed ID: 21570308
[TBL] [Abstract][Full Text] [Related]
36. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
37. Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.
Franke L; Byvatov E; Werz O; Steinhilber D; Schneider P; Schneider G
J Med Chem; 2005 Nov; 48(22):6997-7004. PubMed ID: 16250658
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
Eissa AA; Farag NA; Soliman GA
Bioorg Med Chem; 2009 Jul; 17(14):5059-70. PubMed ID: 19527932
[TBL] [Abstract][Full Text] [Related]
39. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.
Miyamoto K; Miyake S; Mizuno M; Oka N; Kusunoki S; Yamamura T
Brain; 2006 Aug; 129(Pt 8):1984-92. PubMed ID: 16835249
[TBL] [Abstract][Full Text] [Related]
40. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
